Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Better Therapeutics, Inc. (BTTX)
OTHER OTC:BTTX
RESEARCH TOOLSreports
Better Therapeutics, Inc. (BTTX) Stock Price & Analysis
164 Followers
BTTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $1.55
Previous Close$0.01
Volume254.84K
Average Volume (3M)6.48M
Market Cap
$538.09K
Enterprise Value$8.25M
Total Cash (Recent Filing)$6.60M
Total Debt (Recent Filing)$14.31M
Price to Earnings (P/E)>-0.1
Beta1.58
Next Earnings
May 10, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.16
Shares Outstanding47,403,398
10 Day Avg. Volume877,169
30 Day Avg. Volume6,477,885
Standard Deviation0.36
R-Squared0.09
Alpha-0.10
Financial Highlights & Ratios
Price to Book (P/B)-0.04
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Better Therapeutics, Inc. News
PremiumCompany Announcements
Better Therapeutics Overhaul and Nasdaq Delisting
PremiumCompany Announcements
Better Therapeutics Issues Investor Presentation with Cautions
PremiumCompany Announcements
Better Therapeutics CEO Discusses Future on Bloomberg TV
Ownership Overview
46.45% Insiders
1.27% Mutual Funds
0.79% Other Institutional Investors
51.49% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BTTX FAQ
What was Better Therapeutics, Inc.’s price range in the past 12 months?
Better Therapeutics, Inc. lowest stock price was <$0.01 and its highest was $1.55 in the past 12 months.
What is Better Therapeutics, Inc.’s market cap?
Currently, no data Available
When is Better Therapeutics, Inc.’s upcoming earnings report date?
Better Therapeutics, Inc.’s upcoming earnings report date is May 10, 2024 which is in 22 days.
How were Better Therapeutics, Inc.’s earnings last quarter?
Currently, no data Available
Is Better Therapeutics, Inc. overvalued?
According to Wall Street analysts Better Therapeutics, Inc.’s price is currently Overvalued.
Does Better Therapeutics, Inc. pay dividends?
Better Therapeutics, Inc. does not currently pay dividends.
What is Better Therapeutics, Inc.’s EPS estimate?
Better Therapeutics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Better Therapeutics, Inc. have?
Better Therapeutics, Inc. has 54,352,497 shares outstanding.
What happened to Better Therapeutics, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Better Therapeutics, Inc.?
Among the largest hedge funds holding Better Therapeutics, Inc.’s share is Farallon Capital Management, L.L.C.. It holds Better Therapeutics, Inc.’s shares valued at N/A.
---
Better Therapeutics, Inc. Stock Smart Score
Company Description
Better Therapeutics, Inc.
Mountain Crest Acquisition Corp II is a blank check company.
---
BTTX Earnings Call
Q3 2023
0:00 / 0:00
---
BTTX Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BTTX
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-77.60%
reiterated a buy rating 5 months ago
Copying Thomas Flaten's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -77.60% per trade.
---